本刊讯日前,经国家食品药品监督管理局批准,抗艾滋病病毒新药“克艾特胶囊”通过国家药品审评中心审评,进入Ⅱ期临床试验阶段。同时该药还通过了科技部、国家中医药管理局审评,被列为“十五”国家攻关项目。据悉,该药是中国中医研究院莫以贤教授带领广东省湛江市贤博科技有限公 Recently, with the approval of the State Food and Drug Administration, the new anti-HIV drug, Keate Capsule, has been reviewed by the National Center for Drug Evaluation and has entered Phase II clinical trials. At the same time, the drug has also passed the review of the Ministry of Science and Technology and the State Administration of Traditional Chinese Medicine, and it has been listed as a National Key Project for the Tenth Five-year Plan. It is reported that the drug is led by Prof. Mo Yixian of the Chinese Academy of Traditional Chinese Medicine and led by Yinbo Science and Technology Co., Ltd. of Zhanjiang City, Guangdong Province.